Luciana Cadore Stefani

Luciana Cadore Stefani

Auto-generated profile, based on publicly available information

Luciana Cadore Stefani

From the Department of Anesthesia and Perioperative Medicine, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Neuroscience Letters
Verified
Journal Article
Open access
LSLuciana Cadore Stefani
Luciana Cadore Stefani
FLFabricio M. Leite
Fabricio M. Leite
MTMaria da Graça L. Tarragó
Maria da Graça L. Tarragó
SZSimone A. Zanette
Simone A. Zanette
ASAndressa de Souza
Andressa de Souza
WCWolnei Caumo
Wolnei Caumo
Central sensitivity syndrome (CSS) consists of adaptive pathophysiological changes associated with neuroplasticity in some chronic pain disorders. It could be grouped in two main conceptual conditions: one includes those chronic pain patients without overt structural pathology such as fibromyalgia, and the other subgroup includes conditions with recognizable structural abnormalities, both somatic (osteoarthritis) and visceral (endometriosis). In order to understand the role of neuromodulators in CCS we aim to determine whether brain-derived neurotrophic factor (BDNF) and S100B are associated to specific chronic pain disorders. Serum BDNF and S100B were measured in chronic pain women with different diagnosis: 88 with osteoarthritis, 36 with endometriosis, 117 with fibromyalgia, 33 with chronic tension type headache and in 41 healthy controls. ANCOVA analysis followed by heteroscedasticity-consistent covariance matrix was performed to evaluate BDNF and S100B levels, adjusted for depression severity, pain levels and use of analgesics according different pathologies. Serum BDNF concentrations were higher and not different in patients with fibromyalgia and headache, the CSS group without structural pathology. In contrast, the concentrations of S100B were higher in patients with osteoarthritis and endometriosis, in comparison to controls, fibromyalgia and tensional headache patients. This study supports the hypothesis that BDNF and S100B neuromodulators present different serum levels according to the background disease associated to the chronic pain. These have the potential to be studied as markers of active disease or treatment evolution.

1 September 2018 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
LSLuciana C. Stefani
Luciana C. Stefani
PGPatricia W. Gamermann
Patricia W. Gamermann
ABAmanda Backof
Amanda Backof
FGFernanda Guollo
Fernanda Guollo
RBRafael M.J. Borges
Rafael M.J. Borges
EFElaine A. Felix
Elaine A. Felix

30 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LSLuciana Cadore Stefani
Luciana Cadore Stefani
CGClaudia De Souza Gutierrez
Claudia De Souza Gutierrez
SCStela Maris De Jezus Castro
Stela Maris De Jezus Castro
RZRafael Leal Zimmer
Rafael Leal Zimmer
FDFelipe Polgati Diehl
Felipe Polgati Diehl
WCWolnei Caumo
Wolnei Caumo
Ascertaining which patients are at highest risk of poor postoperative outcomes could improve care and enhance safety. This study aimed to construct and validate a propensity index for 30-day postoperative mortality. A retrospective cohort study was conducted at Hospital de Clínicas de Porto Alegre, Brazil, over a period of 3 years. A dataset of 13524 patients was used to develop the model and another dataset of 7254 was used to validate it. The primary outcome was 30-day in-hospital mortality. Overall mortality in the development dataset was 2.31% [n = 311; 95% confidence interval: 2.06–2.56%]. Four variables were significantly associated with outcome: age, ASA class, nature of surgery (urgent/emergency vs elective), and surgical severity (major/intermediate/minor). The index with this set of variables to predict mortality in the validation sample (n = 7253) gave an AUROC = 0.9137, 85.2% sensitivity, and 81.7% specificity. This sensitivity cut-off yielded four classes of death probability: class I, 10%. Model application showed that, amongst patients in risk class IV, the odds of death were approximately fivefold higher (odds ratio 5.43, 95% confidence interval: 2.82–10.46) in those admitted to intensive care after a period on the regular ward than in those sent to the intensive care unit directly after surgery. The SAMPE (Anaesthesia and Perioperative Medicine Service) model accurately predicted 30-day postoperative mortality. This model allows identification of high-risk patients and could be used as a practical tool for care stratification and rational postoperative allocation of critical care resources.

1 February 2021 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
CGClaudia S. Gutierrez
Claudia S. Gutierrez
SPSávio C. Passos
Sávio C. Passos
SCStela M.J. Castro
Stela M.J. Castro
LOLucas S.M. Okabayashi
Lucas S.M. Okabayashi
MBMariana L. Berto
Mariana L. Berto
LSLuciana C. Stefani
Luciana C. Stefani


8 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AWAnelise Schifino Wolmeister
Anelise Schifino Wolmeister
CSCarolina Lourenzon Schiavo
Carolina Lourenzon Schiavo
KNKahio César Kuntz Nazário
Kahio César Kuntz Nazário
SCStela Maris de Jezus Castro
Stela Maris de Jezus Castro
ASAndressa de Souza
Andressa de Souza
LSLuciana Cadore Stefani
Luciana Cadore Stefani
Preoperative patients’ vulnerabilities such as physical, social, and psychological are implicated in postoperative pain variability. Nevertheless, it is a challenge to analyze a patient's psychological profile in the preoperative period in a practical and consistent way. Thus, we sought to identify if high preoperative emotional stress, evaluated by the Brief Measure of Emotional Preoperative Stress (B-MEPS) scale is associated with higher postoperative pain levels and poor rehabilitation in patients submitted to intermediate or major surgery. Moreover, the possible neurobiological or neurophysiological mechanisms implicated in high preoperative emotional stress, evaluated through preoperative quantitative sensory pain tests and serum biomarkers BDNF and S100B were investigated. We conducted a prospective, observational, cohort study of ASA 2 and 3 adult patients undergoing major urologic, gynecologic, proctologic and orthopedic surgeries from March 2017 to March 2018. B-MEPS and Central Sensitivity Inventory were evaluated preoperatively, followed by a sequence of experimental pain tests and serum biomarkers collection. Postoperative evaluation carried out within the first 48 hours after surgery comprehended pain at rest and movement-evoked pain, and the consumption of morphine. Quality-of-Recovery was also evaluated in the 3rd postoperative day. 23 (15%) out of 150 patients included in the study presented high emotional preoperative stress. Variables significantly related to preoperative stress were: previous psychiatric diagnosis and Central Sensitization Inventory result. Mean movement-evoked pain in the first 12 to 48 hours was 95–105% higher than pain at rest. A mixed model for repeated measures showed a sustainable effect of B-MEPS as a movement-evoked pain predictor. Previous pain, cancer surgery, and preoperative pressure pain tolerance were also independent predictors of postoperative pain. Moderate to severe postoperative movement-evoked pain was predictive of poor rehabilitation in 48 hours after surgery. We confirmed that a brief screening method of preoperative emotional states could detect individuals prone to experience severe postoperative pain. Specific interventions considering the stress level may be planned in the future to improve perioperative outcomes.